United Therapeutics Corporation
Paul A Mahon (EVP & GENERAL COUNSEL) sells UTHR shares
AI-generated summary
Paul A Mahon, EVP & GENERAL COUNSEL of United Therapeutics Corp., exercised 8,300 stock options at an average price of $146.03 for a value of $1,212,049 and subsequently sold 8,300 shares at an average price of $544.30 for a value of $4,517,708.96. Following these transactions, the insider directly held 45,172 shares of common stock. The transactions were executed under a Rule 10b5-1 trading plan adopted on August 11, 2025.
Key facts
- Insider
- Paul A Mahon · EVP & GENERAL COUNSEL
Rule 10b5-1 plan
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +8,300 | $146.03 | $1,212,049.00 | 53,472 | Direct |
| Oct 15, 2026 | S · open-market saleFootnotes F1, F2 | −268 | $541.64 | $145,160.08 | 53,204 | Direct |
| Oct 15, 2026 | S · open-market saleFootnotes F1, F3 | −1,924 | $542.49 | $1,043,753.45 | 51,280 | Direct |
| Oct 15, 2026 | S · open-market saleFootnotes F1, F4 | −1,983 | $543.56 | $1,077,870.75 | 49,297 | Direct |
| Oct 15, 2026 | S · open-market saleFootnotes F1, F5 | −791 | $544.85 | $430,975.16 | 48,506 | Direct |
| Oct 15, 2026 | S · open-market saleFootnotes F1, F6 | −2,615 | $545.69 | $1,426,972.29 | 45,891 | Direct |
| Oct 15, 2026 | S · open-market saleFootnotes F1, F7 | −719 | $546.56 | $392,977.22 | 45,172 | Direct |
| Oct 15, 2026 | M · exercise or conversion of a derivativeStock OptionFootnotes F1 | −8,300 | $0.00 | $0.00 | 30,940 | Direct |
Footnotes
- F1 This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.
- F2 This transaction was executed in multiple trades at prices ranging from $541.015 to $541.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3 This transaction was executed in multiple trades at prices ranging from $542.035 to $542.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4 This transaction was executed in multiple trades at prices ranging from $543.155 to $544.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5 This transaction was executed in multiple trades at prices ranging from $544.22 to $545.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6 This transaction was executed in multiple trades at prices ranging from $545.23 to $546.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7 This transaction was executed in multiple trades at prices ranging from $546.27 to $547.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
More UTHR filings
- 4
Filed Nov 6, 2026
- 4
Filed Nov 6, 2026
- 4
Filed Nov 5, 2026
- 4
Filed Nov 5, 2026
- 4
Filed Nov 5, 2026
- 144
Filed Nov 5, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.